Aptevo Therapeutics (APVO) director reports vesting and conversion of 400 RSUs
Rhea-AI Filing Summary
Aptevo Therapeutics Inc. director Barbara Lopez Kunz reported the vesting and conversion of 400 Restricted Stock Units (RSUs) into 400 shares of common stock on August 6, 2026. The RSUs convert into common stock on a one-for-one basis. These 400 RSUs were part of a grant of 7,200 RSUs (400 post-split) awarded on August 6, 2025, which vested on the first anniversary of the grant date.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 400 shares
Net Buy
2 txns
Insider
Kunz Barbara Lopez
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit F1, F2 | 400 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 400 | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 0 shares (Direct);
Common Stock — 400 shares (Direct)
Footnotes (2)
- F1. Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- F2. On August 6, 2025, the reporting person was granted 7,200 (400 post-split) RSUs, vesting on the first anniversary of the date of grant.
Key Figures
RSUs converted: 400 RSUs
Common shares received: 400 shares
Original RSU grant: 7,200 RSUs (400 post-split)
+1 more
4 metrics
RSUs converted
400 RSUs
RSUs converted into common stock on August 6, 2026
Common shares received
400 shares
Shares of common stock issued upon RSU conversion
Original RSU grant
7,200 RSUs (400 post-split)
Granted on August 6, 2025, vesting on first anniversary
Post-transaction common holdings
400 shares
Direct common stock holdings reported after the transaction
Key Terms
Restricted Stock Unit, one-for-one basis, post-split
3 terms
Restricted Stock Unit financial
"Restricted Stock Units ("RSUs") convert into common stock"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
one-for-one basis financial
"RSUs convert into common stock ... on a one-for-one basis"
post-split financial
"the reporting person was granted 7,200 (400 post-split) RSUs"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Aptevo Therapeutics (APVO) report for Barbara Lopez Kunz?
Barbara Lopez Kunz reported the vesting and conversion of 400 RSUs into 400 shares of common stock on August 6, 2026, reflecting an equity compensation event rather than an open-market purchase or sale.
How many Aptevo Therapeutics (APVO) RSUs vested and converted in this Form 4?
A total of 400 Restricted Stock Units vested and converted into 400 shares of common stock. The RSUs convert on a one-for-one basis, meaning each RSU became one share upon vesting.
What was the original RSU grant disclosed in the Aptevo (APVO) Form 4?
On August 6, 2025, the reporting person was granted 7,200 RSUs, noted as 400 post-split RSUs, which were scheduled to vest on the first anniversary of the grant date, leading to this 2026 vesting event.
Did the Aptevo (APVO) Form 4 report any open-market buy or sell transactions?
No open-market buys or sells were reported. The filing shows an exercise/conversion of 400 RSUs into common stock, an equity compensation vesting event without a reported market trade price.